News
Acuitas Therapeutics has announced the publication of a new study in Science Immunology, titled "An IL12 mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responses." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback